Ethema Health Corporation provides a shareholder update on public filings, revenue projections, and operational achievements. Diopter Technologies introduces a groundbreaking dissolving amniotic membrane biopolymer contact lens for ocular surface diseases, aiming to revolutionize ocular surface rehabilitation. Curebound, led by COO Karen Hooper, focuses on accelerating cancer cures through innovative research and fundraising efforts, emphasizing community support in the face of NIH funding cuts.
